Home Podcasts Decera Clinical Insights
Decera Clinical Insights

Decera Clinical Insights

Decera Clinical Insights 7 Episodes Jul 14, 2026

Decera Clinical Insights is a podcast channel that delivers short, focused episodes on clinical topics. It is designed to give listeners quick access to important content whenever they need it, whether at home, at their desk, or on the go. The show is produced by the Decera Clinical Insights team and is aimed at healthcare professionals and others interested in clinical practice. Episodes offer practical, on-demand insight in a convenient format.

Episodes

HIV Viral Blips: Interpretation and Clinical Management in the Era of Modern ART
HIV Viral Blips: Interpretation and Clinical Management in the Era of Modern ART Jul 14, 2026 00:30:52 In this podcast, we examine the rise of viral “blips” in the era of highly sensitive HIV assays. As testing now detects viral loads down to 20 copies/mL, clinicians are increasingly faced with low-level detectable results that are often benign rather than signs of virologic failure. We discuss how to distinguish transient assay “noise” from persistent low-level viremia, review key guideline thresh
Decera Clinical Insights Podcast, Right Test, Right Setting, Integrating Rapid Point-of-Care Testing for Sexual Health into Practice-Segment 2
Decera Clinical Insights Podcast, Right Test, Right Setting, Integrating Rapid Point-of-Care Testing for Sexual Health into Practice-Segment 2 May 22, 2026 00:12:40 Segment 2: Discussion on the operational and logistics aspects of integrating rapid point-of-care testing into clinical workflows. Get access to all of our new podcasts by subscribing to the Decera Clinical Insights Podcast show on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data f
Decera Clinical Insights Podcast, Right Test, Right Setting, Integrating Rapid Point-of-Care Testing for Sexual Health into Practice-Segment 1
Decera Clinical Insights Podcast, Right Test, Right Setting, Integrating Rapid Point-of-Care Testing for Sexual Health into Practice-Segment 1 May 22, 2026 00:24:25 Segment 1: Discussion on the clinical and patient-experience benefits of rapid point-of-care testing for sexually transmitted infections. Get access to all of our new podcasts by subscribing to the Decera Clinical Insights Podcast show on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal
Updates in the Treatment of Patients with EGFR Exon 20 Insertion Mutation NSCLC
Updates in the Treatment of Patients with EGFR Exon 20 Insertion Mutation NSCLC Nov 10, 2023 00:10:17 This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways: - Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC - Review updated clinical data from ELCC and ESMO 2023 - Gain an understanding around the management of treatment-related
Depression in Patients with Cancer
Depression in Patients with Cancer Sep 22, 2021 00:27:56 Presenter:Philip R. Muskin MD, MA, DLFAPAProfessor of PsychiatryColumbia University Irving Medical CenterSenior Consultant in Consultation-Liaison PsychiatryNew York-Presbyterian HospitalNew York, NYChronic medical illnesses such as cancer are characterized by a notably increased prevalence of depression. Furthermore, several challenges may arise in managing the depression in these patients, given
Optimal Treatment of Metastatic TNBC
Optimal Treatment of Metastatic TNBC Sep 21, 2021 00:29:30 Presenter:Hope S. Rugo MDProfessor of MedicineUniversity of CaliforniaSan Francisco Comprehensive Cancer CenterTNBC comprises approximately 15% of newly diagnosed breast cancer cases and is defined by being estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor receptor 2-negative. This breast cancer subtype is very aggressive, with a median overall survival
Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm
Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm Sep 21, 2021 00:27:20 Presenter:Gail J. Roboz MDProfessor of MedicineDirector, Clinical and Translational Leukemia ProgramWeill Medical College of Cornell UniversityNew York-Presbyterian HospitalNew York, New York, United StatesThis brief program will begin with a review of NCCN Guidelines® Recommendations for the treatment of AML in individuals 60 years of age or older. Next, the results of the BRIGHT AML 1003 trial c

Recommended